Diagnostic imaging of the diabetic foot: an EANM evidence-based guidance
Diagnostische Bildgebung des diabetischen Fußes: evidenzbasierte Leitlinie der EANM
European Journal of Nuclear Medicine and Molecular Imaging · 2024-07 · 51 (8) · 2229-2246
DOI: 10.1007/s00259-024-06693-y ↗Auf einen Blick
Die EANM gibt evidenzbasierte Empfehlungen zur Bildgebung bei infektiösen und nicht infektiösen Komplikationen des diabetischen Fußes. MRI, WBC-Szintigraphie und [18F]FDG PET/CT werden je nach klinischer Fragestellung bevorzugt.
Fragestellung
Welche Bildgebung soll bei unterschiedlichen klinischen Situationen beim diabetischen Fuß bevorzugt werden?
Methode
Evidenzbasierte Leitlinie einer EANM-Arbeitsgruppe; systematische Analyse der Literatur nach PICO; Bewertung nach OCEBM.
Ergebnisse
Aus 9 klinischen Fragen wurden 7 evidenzbasierte Empfehlungen abgeleitet. MRI ist meist die erste fortgeschrittene Bildgebung; bei unklaren Befunden kommen WBC-Szintigraphie oder [18F]FDG PET/CT infrage. WBC-Szintigraphie kann bei Charcot-Fuß mit Verdacht auf Infektion genauer sein.
Schlussfolgerung der Autor:innen
Die praktischen Empfehlungen sollen die Rolle der Bildgebung in der Diagnostik von Komplikationen des diabetischen Fußes verdeutlichen und die klinische Einordnung unterstützen.
Kernaussagen
- 7 evidenzbasierte Empfehlungen aus 9 klinischen Fragen
- MRI meist erste fortgeschrittene Bildgebung
- WBC-Szintigraphie oder [18F]FDG PET/CT bei unklaren Befunden
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Leitlinie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 27.03.2024. Verfasst von Chiara Lauri und 13 weiteren Autor:innen. Beteiligte Einrichtung: Inflammation and Infection Committee of the European Association of Nuclear Medicine (EANM), Vienna, Austria. Hauptthemen laut MEDLINE: Diabetic Foot, Evidence-Based Medicine. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetisches Fußsyndrom
Abstract (Originalsprache)
Purpose
Consensus on the choice of the most accurate imaging strategy in diabetic foot infective and non-infective complications is still lacking. This document provides evidence-based recommendations, aiming at defining which imaging modality should be preferred in different clinical settings.
Methods
This working group includes 8 nuclear medicine physicians appointed by the European Association of Nuclear Medicine (EANM), 3 radiologists and 3 clinicians (one diabetologist, one podiatrist and one infectious diseases specialist) selected for their expertise in diabetic foot. The latter members formulated some clinical questions that are not completely covered by current guidelines. These questions were converted into statements and addressed through a systematic analysis of available literature by using the PICO (Population/Problem–Intervention/Indicator–Comparator–Outcome) strategy. Each consensus statement was scored for level of evidence and for recommendation grade, according to the Oxford Centre for Evidence-Based Medicine (OCEBM) criteria.
Results
Nine clinical questions were formulated by clinicians and used to provide 7 evidence-based recommendations: (1) A patient with a positive probe-to-bone test, positive plain X-rays and elevated ESR should be treated for presumptive osteomyelitis (OM). (2) Advanced imaging with MRI and WBC scintigraphy, or [ 18 F]FDG PET/CT, should be considered when it is needed to better evaluate the location, extent or severity of the infection, in order to plan more tailored treatment. (3) In a patient with suspected OM, positive PTB test but negative plain X-rays, advanced imaging with MRI or WBC scintigraphy + SPECT/CT, or with [ 18 F]FDG PET/CT, is needed to accurately assess the extent of the infection. (4) There are no evidence-based data to definitively prefer one imaging modality over the others for detecting OM or STI in fore- mid- and hind-foot. MRI is generally the first advanced imaging modality to be performed. In case of equivocal results, radiolabelled WBC imaging or [ 18 F]FDG PET/CT should be used to detect OM or STI. (5) MRI is the method of choice for diagnosing or excluding Charcot neuro-osteoarthropathy; [ 18 F]FDG PET/CT can be used as an alternative. (6) If assessing whether a patient with a Charcot foot has a superimposed infection, however, WBC scintigraphy may be more accurate than [ 18 F]FDG PET/CT in differentiating OM from Charcot arthropathy. (7) Whenever possible, microbiological or histological assessment should be performed to confirm the diagnosis. (8) Consider appealing to an additional imaging modality in a patient with persisting clinical suspicion of infection, but negative imaging.
Conclusion
These practical recommendations highlight, and should assist clinicians in understanding, the role of imaging in the diagnostic workup of diabetic foot complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Inflammation and Infection Committee of the European Association of Nuclear Medicine (EANM), Vienna, Austria.
- Nuclear Medicine Unit, Department of Medical-Surgical Sciences and of Translational Medicine, Faculty of Medicine and Psychology, "Sapienza" University of Rome, Rome, Italy.
- Department of Nuclear Medicine and Molecular Imaging, University Hospital of Guadalajara, Guadalajara, Spain.
- Radiology Department, Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury, UK.
- Department of Nuclear Medicine and Molecular imaging, University Hospitals Leuven, Leuven, Belgium.
- Inflammation and Infection Committee of the European Association of Nuclear Medicine (EANM), Vienna, Austria. a.w.j.m.glaudemans@umcg.nl.
ORCID-Profile: Andor W J M Glaudemans
Zitieren
APA
Lauri, C., Noriega-Álvarez, E., Chakravartty, R. M., Gheysens, O., Glaudemans, A. W. J. M., Slart, R. H. J. A., Kwee, T. C., Lecouvet, F., Panagiotidis, E., Zhang-Yin, J., Martinez, J. L. L., Lipsky, B. A., Uccioli, L., & Signore, A. (2024). Diagnostic imaging of the diabetic foot: an EANM evidence-based guidance. European Journal of Nuclear Medicine and Molecular Imaging, 51(8), 2229-2246. https://doi.org/10.1007/s00259-024-06693-y
Vancouver
Lauri C, Noriega-Álvarez E, Chakravartty RM, Gheysens O, Glaudemans AWJM, Slart RHJA, et al. Diagnostic imaging of the diabetic foot: an EANM evidence-based guidance. European Journal of Nuclear Medicine and Molecular Imaging. 2024;51(8):2229-2246. doi:10.1007/s00259-024-06693-y
BibTeX
@article{Lauri2024,
author = {Lauri, Chiara and Noriega-Álvarez, Edel and Chakravartty, Riddhika M and Gheysens, Olivier and Glaudemans, Andor W J M and Slart, Riemer H J A and Kwee, Thomas C and Lecouvet, Frédéric and Panagiotidis, Emmanouil and Zhang-Yin, Jules and Martinez, Jose Luis Lazaro and Lipsky, Benjamin A and Uccioli, Luigi and Signore, Alberto},
title = {Diagnostic imaging of the diabetic foot: an EANM evidence-based guidance},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2024},
volume = {51},
number = {8},
pages = {2229--2246},
doi = {10.1007/s00259-024-06693-y}
}
EUVIMED